Inpharma

JELIS gives the good oil on coronary events
pp. 1-1(1)

Little evidence for benefits with direct-to-consumer advertising
pp. 2-2(1)

EU debate over industry direct-to-patient information
pp. 3-3(1)

Is it curtains for the blockbuster model?
pp. 3-3(1)

Economics of expanded hepatitis A vaccination "reasonable"
pp. 3-3(1)

Influenza virus vaccine uptake is low among healthcare workers in Victoria, Australia
pp. 3-3(1)

Voriconazole best value for invasive aspergillosis in Spain
pp. 4-4(1)

Rizatriptan, eletriptan most cost-effective oral triptans for migraine?
pp. 4-4(1)

Antithrombotics are prescribed to most outpatients with permanent atrial fibrillation (AF), however the use of vitamin K antagonists decreases with age.
pp. 4-4(1)

Aspirin has "favourable" cost utility in older women
pp. 4-4(1)

Tolvaptan a possible adjunct treatment for heart failure
pp. 5-6(2)

Naproxen/sumatriptan tops either drug alone for migraine
pp. 7-7(1)

Treatments for multidrug-resistant malaria evaluated
pp. 7-7(1)

Melatonin has therapeutic effects in patients with functional dyspepsia
pp. 7-7(1)

Topical interferon-α-2b appears to be effective against cervical intraepithelial neoplasia
pp. 7-7(1)

Patients with hormone-refractory, metastatic prostate cancer treated with GVAX cancer vaccine have demonstrated encouraging survival outcomes
pp. 7-7(1)

A combination of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) appears promising for locally advanced and metastatic pancreatic cancer
pp. 8-8(1)

Prednisolone/paroxetine [CRx 139] may be effective in rheumatoid arthritis
pp. 8-8(1)

Paliperidone goes the distance in schizophrenia
pp. 8-8(1)

Highly significant results with CDB 4124 in uterine leiomyoma
pp. 8-8(1)

Bronchial thermoplasty: a hot new therapy for asthma
pp. 9-9(1)

A two-dose methotrexate regimen is effective for ectopic pregnancy treatment
pp. 9-9(1)

Methylprednisolone prevents postextubation laryngeal oedema
pp. 9-9(1)

Adjunct collagen sponge-based local gentamicin delivery reduces the incidence of postoperative sternal wound infections
pp. 9-9(1)

Fortnightly darbepoetin-α is effective for maintaining haemoglobin (Hb) levels in dialysis patients previously treated with epoetia-α or -β
pp. 9-9(1)

Statins reduce risk of sepsis in patients requiring dialysis
pp. 10-10(1)

Sildenafil beneficial for BPH-related symptoms
pp. 10-10(1)

Artemether/lumefantrine beats standard antimalarial combo
pp. 10-10(1)

Telmisartan more promising than amlodipine for metabolic syndrome
pp. 10-10(1)

Rosuvastatin still shining in coronary atherosclerosis
pp. 11-12(2)

Paclitaxel adds benefit to ifosfamide in uterine cancer
pp. 12-12(1)

Oral decontamination an infectious idea in ventilated patients
pp. 13-13(1)

A combination of decitabine and imatinib may be effective against chronic myeloid leukaemia
pp. 13-13(1)

A cholestin extract, xuezhikang, effectively reduces cardiovascular events for patients with type 2 diabetes mellitus (T2DM) and coronary heart disease
pp. 13-13(1)

Antiretroviral drugs administered during the last trimester of pregnancy and after birth decrease HIV RNA levels in breast milk
pp. 13-13(1)

Antidepressant treatment may promote long-term improvement of executive function after stroke
pp. 13-13(1)

Sialidase inhibitors: influenza B virus resistance emerges
pp. 14-14(1)

Levetiracetam noninferior to carbamazepine for new epilepsy
pp. 14-14(1)

ART during pregnancy has no link with preterm delivery, overall
pp. 14-14(1)

Adalimumab ADEPT in real-life clinical practice, results in STEREO
pp. 15-16(2)

Magnesium sulfate in pregnancy: longer term safety reassurance
pp. 16-16(1)

Once-daily ropinirole reduces 'off' time in Parkinson's disease
pp. 16-16(1)

Lopinavir/ritonavir levels "may remain subtherapeutic with standard dosing" in some pregnant women with HIV infection
pp. 17-17(1)

Nortriptyline plus citalopram is more effective than citalopram alone in patients with severe major depression
pp. 17-17(1)

Extended-release (ER) oxymorphone exhibits effective pain relief in opoid-experienced patients with chronic low back pain
pp. 17-17(1)

Reduced-dose ciclosporin successful in renal transplantation
pp. 17-17(1)

Long-acting injectable risperidone is more effective than oral risperidone for psychosis
pp. 18-18(1)

Anticoagulant prophylaxis reduces VTE risk for medical patients
pp. 18-18(1)

Combined oral contraceptive pills (OCPs) appear to decrease the risk of epithelial ovarian cancer
pp. 18-18(1)

TEGAFOX and TEGAFIRI effective for colorectal cancer
pp. 18-18(1)

Zinc sulfate does not prevent or cure taste alteration in patients receiving radiotherapy
pp. 18-18(1)

Clopidogrel plus aspirin demonstrates platelet inhibition in congestive heart failure (CHF), regardless of major clinical characteristics of the disease
pp. 19-19(1)

A once-daily regimen of mesalazine has bioequivalence with a twice-daily regimen
pp. 19-19(1)

Controlled-release (CR) oxybutynin may be more convenient than immediate-release (IR) oxybutynin
pp. 19-19(1)

Pegvisomant shows potential for GH dependant cancers
pp. 19-19(1)

Sufficient levels of levofloxacin penetrate the aqueous humour to prevent bacterial infection following ocular surgery
pp. 19-19(1)

The Japanese Ministry for Health, Labour and Welfare has stated that doctors are no longer to prescribe oseltamivir
pp. 20-20(1)

Health Canada warns against using Vigorect Oral Gel Shooter
pp. 20-20(1)

Pergolide pulled from US market
pp. 20-20(1)

Restricted use, stronger warnings for Ketek in Europe
pp. 20-20(1)

Bayer issues new Trasylol safety info in Canada
pp. 21-21(1)

Zelnorm withdrawn from the US, Canadian market
pp. 21-21(1)

Health Canada advises that labelling for Tamiflu [oseltamivir] has been revised
pp. 21-21(1)

Mortality higher for AD patients on neuroleptics
pp. 21-21(1)

Increased mortality with epoetin-α
pp. 22-22(1)

EU product approvals
pp. 22-22(1)

US product approvals
pp. 22-22(1)

New Drug Interaction Probability Scale available
pp. 22-22(1)

Health Canada has granted a notice of compliance for Bristol-Myers Squibb's dasatinib [Sprycel] for use in patients with chronic myeloid leukaemia
pp. 23-23(1)

Encysive Pharmaceuticals has launched sitaxentan [Thelin] 100mg tablets for pulmonary arterial hypertension (PAH) in Ireland.
pp. 23-23(1)

Angiotech Pharmaceuticals and Boston Scientific Corporation's paclitaxel-eluting coronary stent system [Taxus Express2] has been approved in Japan
pp. 23-23(1)